tolevamer potassium-sodium (GT267-004)

DRUG3 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

Antibiotic-Associated DiarrheaClostridium Difficile DiarrheaClostridium EnterocolitisDiarrheaPseudomembranous Colitis

Phase 2

A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

CompletedNCT00382304

Genzyme, a Sanofi CompanyAntibiotic-Associated Diarrhea, Clostridium Difficile Diarrhea, Pseudomembranous Colitis

Start: 2006-09-30End: 2007-09-30Target: 24Updated: 2015-03-19

Phase 3

A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

CompletedNCT00106509

Genzyme, a Sanofi CompanyClostridium Enterocolitis, Pseudomembranous Colitis

Start: 2005-03-31End: 2007-02-28Target: 520Updated: 2015-03-05

A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

CompletedNCT00196794

Genzyme, a Sanofi CompanyClostridium Enterocolitis, Diarrhea

Start: 2005-04-30End: 2007-08-31Updated: 2014-03-19

Related Papers

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Clinical Infectious Diseases2014-05-05509 citations